These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28784162)

  • 1. Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine.
    Advani G; Lim YC; Catimel B; Lio DSS; Ng NLY; Chüeh AC; Tran M; Anasir MI; Verkade H; Zhu HJ; Turk BE; Smithgall TE; Ang CS; Griffin M; Cheng HC
    Cell Commun Signal; 2017 Aug; 15(1):29. PubMed ID: 28784162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-terminal Src kinase-homologous kinase (CHK), a unique inhibitor inactivating multiple active conformations of Src family tyrosine kinases.
    Chong YP; Chan AS; Chan KC; Williamson NA; Lerner EC; Smithgall TE; Bjorge JD; Fujita DJ; Purcell AW; Scholz G; Mulhern TD; Cheng HC
    J Biol Chem; 2006 Nov; 281(44):32988-99. PubMed ID: 16959780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel non-catalytic mechanism employed by the C-terminal Src-homologous kinase to inhibit Src-family kinase activity.
    Chong YP; Mulhern TD; Zhu HJ; Fujita DJ; Bjorge JD; Tantiongco JP; Sotirellis N; Lio DS; Scholz G; Cheng HC
    J Biol Chem; 2004 May; 279(20):20752-66. PubMed ID: 14985335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.
    Chong YP; Mulhern TD; Cheng HC
    Growth Factors; 2005 Sep; 23(3):233-44. PubMed ID: 16243715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between the tyrosine kinases Chk and Csk and phosphatase PTPRJ is critical for regulating platelets in mice.
    Nagy Z; Mori J; Ivanova VS; Mazharian A; Senis YA
    Blood; 2020 Apr; 135(18):1574-1587. PubMed ID: 32016283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases.
    Chong YP; Ia KK; Mulhern TD; Cheng HC
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):210-20. PubMed ID: 16198159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural elements and allosteric mechanisms governing regulation and catalysis of CSK-family kinases and their inhibition of Src-family kinases.
    Ia KK; Mills RD; Hossain MI; Chan KC; Jarasrassamee B; Jorissen RN; Cheng HC
    Growth Factors; 2010 Oct; 28(5):329-50. PubMed ID: 20476842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the substrate specificity determinants recognized by the active site of C-terminal Src kinase-homologous kinase (CHK) and identification of β-synuclein as a potential CHK physiological substrate.
    Ia KK; Jeschke GR; Deng Y; Kamaruddin MA; Williamson NA; Scanlon DB; Culvenor JG; Hossain MI; Purcell AW; Liu S; Zhu HJ; Catimel B; Turk BE; Cheng HC
    Biochemistry; 2011 Aug; 50(31):6667-77. PubMed ID: 21699177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the procedures for high-yield expression and rapid purification of active recombinant Csk-homologous kinase (CHK): comparison of the catalytic activities of CHK and CSK.
    Chan KC; Lio DS; Dobson RC; Jarasrassamee B; Hossain MI; Roslee AK; Ia KK; Perugini MA; Cheng HC
    Protein Expr Purif; 2010 Dec; 74(2):139-47. PubMed ID: 20667476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSK-homologous kinase (CHK/MATK) is a potential colorectal cancer tumour suppressor gene epigenetically silenced by promoter methylation.
    Chüeh AC; Advani G; Foroutan M; Smith J; Ng N; Nandurkar H; Lio DS; Zhu HJ; Chong YP; Verkade H; Fujita DJ; Bjorge J; Basheer F; Lim JP; Luk I; Dhillon A; Sakthianandeswaren A; Mouradov D; Sieber O; Hollande F; Mariadason JM; Cheng HC
    Oncogene; 2021 Apr; 40(17):3015-3029. PubMed ID: 33767439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation.
    Ayrapetov MK; Nam NH; Ye G; Kumar A; Parang K; Sun G
    J Biol Chem; 2005 Jul; 280(27):25780-7. PubMed ID: 15890649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
    Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
    Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased CHK protein levels are associated with Src activation in colon cancer cells.
    Zhu S; Bjorge JD; Cheng HC; Fujita DJ
    Oncogene; 2008 Mar; 27(14):2027-34. PubMed ID: 17934522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Csk homologous kinase (CHK), unlike Csk, enhances MAPK activation via Ras-mediated signaling in a Src-independent manner.
    Zagozdzon R; Kaminski R; Fu Y; Fu W; Bougeret C; Avraham HK
    Cell Signal; 2006 Jun; 18(6):871-81. PubMed ID: 16168623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation, targets and functions of CHK.
    Zhu S; Sun R; Guo X; Bao Y; Zhang D
    Front Cell Dev Biol; 2022; 10():1068952. PubMed ID: 36568988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conserved hydrophobicity in the SH2-kinase linker is required for catalytic activity of Csk and CHK.
    Mikkola ET; Bergman M
    FEBS Lett; 2003 Jun; 544(1-3):11-4. PubMed ID: 12782282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression, purification, and biochemical characterization of Chk, a soluble protein tyrosine kinase.
    Ayrapetov MK; Lee S; Sun G
    Protein Expr Purif; 2003 Jun; 29(2):148-55. PubMed ID: 12767803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Csk homologous kinase (CHK) and ErbB-2 interactions are directly coupled with CHK negative growth regulatory function in breast cancer.
    Kim S; Zagozdzon R; Meisler A; Baleja JD; Fu Y; Avraham S; Avraham H
    J Biol Chem; 2002 Sep; 277(39):36465-70. PubMed ID: 12122014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global phosphoproteomics reveals crosstalk between Bcr-Abl and negative feedback mechanisms controlling Src signaling.
    Rubbi L; Titz B; Brown L; Galvan E; Komisopoulou E; Chen SS; Low T; Tahmasian M; Skaggs B; Müschen M; Pellegrini M; Graeber TG
    Sci Signal; 2011 Mar; 4(166):ra18. PubMed ID: 21447799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Csk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferation.
    Zrihan-Licht S; Deng B; Yarden Y; McShan G; Keydar I; Avraham H
    J Biol Chem; 1998 Feb; 273(7):4065-72. PubMed ID: 9461599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.